tiprankstipranks
Trending News
More News >
Medius Holdings Co., Ltd. (JP:3154)
:3154
Japanese Market

Medius Holdings Co., Ltd. (3154) AI Stock Analysis

Compare
1 Followers

Top Page

JP

Medius Holdings Co., Ltd.

(3154)

Rating:62Neutral
Price Target:
¥986.00
▲(11.66%Upside)
Medius Holdings Co., Ltd.'s overall stock score reflects a solid financial foundation with strong revenue growth and stable profitability, although cash flow fluctuations present a risk. The technical analysis indicates a bearish trend, impacting the score negatively. Valuation metrics are reasonable, providing a balanced outlook.

Medius Holdings Co., Ltd. (3154) vs. iShares MSCI Japan ETF (EWJ)

Medius Holdings Co., Ltd. Business Overview & Revenue Model

Company DescriptionMedius Holdings Co., Ltd. (3154) is a Japan-based company primarily engaged in the wholesale distribution of medical devices and equipment. The company operates through various sectors including the sale of medical supplies, management of medical facilities, and provision of medical-related services. Medius Holdings focuses on delivering high-quality products and solutions that cater to the healthcare industry, aiming to improve patient care and operational efficiencies in medical institutions.
How the Company Makes MoneyMedius Holdings Co., Ltd. generates revenue through the wholesale distribution of medical devices and equipment to hospitals, clinics, and other healthcare providers. The company's revenue model is centered around the procurement and supply of a wide range of medical products, ranging from basic supplies to advanced medical devices. Key revenue streams include direct sales to healthcare institutions, long-term contracts with hospitals, and partnerships with medical equipment manufacturers. Additionally, the company may engage in collaborative ventures and alliances that enhance its distribution network and expand its market reach, thereby contributing to its earnings.

Medius Holdings Co., Ltd. Financial Statement Overview

Summary
Medius Holdings Co., Ltd. demonstrates strong revenue growth and consistent profitability margins. However, cash flow fluctuations, particularly in free cash flow, pose a risk that needs attention for sustained financial health.
Income Statement
75
Positive
Medius Holdings Co., Ltd. shows a strong revenue growth trajectory with recent TTM data indicating a rise in total revenue. The gross profit margin is stable, reflecting efficient cost management. However, the net profit margin has shown some volatility, which could be a concern. EBIT and EBITDA margins are consistent, suggesting operational stability.
Balance Sheet
70
Positive
The company's balance sheet reveals a moderate debt-to-equity ratio, indicating a balanced approach to leverage. The return on equity is healthy, demonstrating effective utilization of shareholder funds. The equity ratio is satisfactory, reflecting a solid asset base supported by equity.
Cash Flow
65
Positive
Cash flow analysis shows fluctuations in free cash flow, influenced by capital expenditure dynamics. Despite operating cash flow being zero in the latest TTM data, previous periods have shown positive cash flow generation. The company needs to focus on sustaining free cash flow for long-term stability.
BreakdownTTMJun 2024Jun 2023Jun 2022Jun 2021Jun 2020
Income Statement
Total Revenue275.78B259.79B239.05B221.69B246.79B210.39B
Gross Profit32.28B31.09B29.31B27.42B25.20B22.27B
EBITDA3.62B3.86B4.27B3.80B4.14B2.11B
Net Income1.03B1.12B1.50B1.87B2.07B951.36M
Balance Sheet
Total Assets119.80B114.83B97.46B92.95B84.44B69.97B
Cash, Cash Equivalents and Short-Term Investments14.00B13.66B10.36B9.11B12.67B8.54B
Total Debt25.23B24.17B19.57B17.82B11.60B9.31B
Total Liabilities99.82B95.09B78.88B75.65B68.59B56.10B
Stockholders Equity19.98B19.74B18.57B17.31B15.84B13.87B
Cash Flow
Free Cash Flow0.00261.12M300.65M-8.49B2.93B185.14M
Operating Cash Flow0.001.92B1.22B-3.90B6.85B1.17B
Investing Cash Flow0.00-2.67B-862.94M-4.82B-4.62B138.45M
Financing Cash Flow0.004.01B862.90M5.21B1.90B787.57M

Medius Holdings Co., Ltd. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price883.00
Price Trends
50DMA
932.63
Negative
100DMA
915.50
Negative
200DMA
865.11
Positive
Market Momentum
MACD
-16.40
Positive
RSI
26.80
Positive
STOCH
3.68
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3154, the sentiment is Negative. The current price of 883 is below the 20-day moving average (MA) of 919.62, below the 50-day MA of 932.63, and above the 200-day MA of 865.11, indicating a neutral trend. The MACD of -16.40 indicates Positive momentum. The RSI at 26.80 is Positive, neither overbought nor oversold. The STOCH value of 3.68 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:3154.

Medius Holdings Co., Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
84
Outperform
¥5.06B8.14
2.59%4.93%-0.26%
76
Outperform
¥5.84B7.48
1.83%8.60%33.64%
66
Neutral
¥14.41B13.19
3.15%2.58%-53.08%
62
Neutral
¥19.64B14.55
2.15%14.12%56.92%
61
Neutral
¥70.51B16.26
3.14%15.55%42.14%
56
Neutral
¥10.53B118.63
3.94%6.83%
51
Neutral
$7.50B0.32-61.87%2.27%17.10%1.59%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:3154
Medius Holdings Co., Ltd.
883.00
10.20
1.17%
JP:4556
Kainos Laboratories, Inc.
1,228.00
80.62
7.03%
JP:7702
JMS Co., Ltd.
434.00
-81.01
-15.73%
JP:7743
Seed Co., Ltd.
474.00
-87.58
-15.60%
JP:7979
Shofu Inc.
1,948.00
-454.14
-18.91%
JP:7980
Shigematsu Works Co., Ltd.
840.00
77.13
10.11%

Medius Holdings Co., Ltd. Corporate Events

Medius Holdings Completes Logistics Division Reorganization
Jul 1, 2025

Medius Holdings Co., Ltd. has completed the internal reorganization of its logistics division by transferring it to a wholly owned subsidiary, now renamed Mediris Logistics Co., Ltd. This company split is expected to have an immaterial impact on the company’s overall business results, indicating a strategic move to streamline operations without disrupting financial performance.

Medius Holdings Reports Strong Q3 Financial Growth Amid Strategic Expansion
May 9, 2025

Medius Holdings Co., Ltd. reported significant financial growth for the third quarter ended March 31, 2025, with net sales increasing by 13.7% and operating profit rising by 22.6% compared to the previous year. The inclusion of two new companies in its consolidation scope reflects Medius Holdings’ strategic expansion, potentially enhancing its market position and offering improved services to stakeholders.

Medius Holdings Restructures Logistics Division for Enhanced Efficiency
Apr 18, 2025

Medius Holdings Co., Ltd. announced a strategic restructuring of its logistics division through a simplified absorption-type company split, effective July 1, 2025. This move aims to enhance logistics management, standardize processes, and invest in logistics solutions to improve productivity and reduce costs, thereby strengthening the company’s operational efficiency and market position.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jun 27, 2025